Literature DB >> 16181125

Cerebrovascular damage as a cause for Alzheimer's disease.

Christian Humpel1, Josef Marksteiner.   

Abstract

Alzheimer's disease is a progressive brain disorder that gradually destroys a patient's memory function and ability to carry out daily activities. According to the prevailing amyloid cascade hypothesis, Alzheimer's disease is initiated by amyloid beta-peptide accumulation leading to neuronal toxicity. The neurofibrillary tangle deriving from hyperphosphorylated tau and synapse loss are also key features for Alzheimer's disease. Recent studies revealed a significant co-morbidity of Alzheimer's disease and cerebrovascular disease suggesting that cerebrovascular dysregulation is an important feature of Alzheimer's disease. This mini-review will discuss the hypothesis that a dysfunction of the vascular system may result in damage of the neurovascular unit, initiating a cascade of events. An overlap with other forms of cognitive impairment, such as mild cognitive impairment, or vascular dementia will be discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16181125     DOI: 10.2174/156720205774322610

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  21 in total

1.  Neurovascular changes measured by time-of-flight MR angiography in cholesterol-fed rabbits with cortical amyloid beta-peptide accumulation.

Authors:  Susan K Lemieux; Carrie A Smith-Bell; Jered R Wells; Nnadozie M Ezerioha; Jeffrey S Carpenter; D Larry Sparks; Bernard G Schreurs
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

Review 2.  Pathophysiology of the neurovascular unit: disease cause or consequence?

Authors:  Danica B Stanimirovic; Alon Friedman
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-07       Impact factor: 6.200

Review 3.  A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease.

Authors:  Renato X Santos; Sónia C Correia; Xinglong Wang; George Perry; Mark A Smith; Paula I Moreira; Xiongwei Zhu
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 4.  Natural secretory products of human neural and microvessel endothelial cells: Implications in pathogenic "spreading" and Alzheimer's disease.

Authors:  Yuhai Zhao; Jian-Guo Cui; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

Review 5.  Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease.

Authors:  Renato X Santos; Sónia C Correia; Xiongwei Zhu; Mark A Smith; Paula I Moreira; Rudy J Castellani; Akihiko Nunomura; George Perry
Journal:  Antioxid Redox Signal       Date:  2012-12-07       Impact factor: 8.401

6.  Carotid intima-media thickness as a predictor of response to cholinesterase inhibitors in Alzheimer's disease: an open-label trial.

Authors:  Pedro J Modrego; Consuelo Rios; José M Pérez Trullen; Maria J García-Gómara; José M Errea
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Simultaneous imaging of cerebral partial pressure of oxygen and blood flow during functional activation and cortical spreading depression.

Authors:  Sava Sakadzić; Shuai Yuan; Ergin Dilekoz; Svetlana Ruvinskaya; Sergei A Vinogradov; Cenk Ayata; David A Boas
Journal:  Appl Opt       Date:  2009-04-01       Impact factor: 1.980

8.  Blood pressure and brain injury in older adults: findings from a community-based autopsy study.

Authors:  Lucy Y Wang; Eric B Larson; Joshua A Sonnen; Jane B Shofer; Wayne McCormick; James D Bowen; Thomas J Montine; Ge Li
Journal:  J Am Geriatr Soc       Date:  2009-09-28       Impact factor: 5.562

9.  Independent effects of intra- and extracellular Abeta on learning-related gene expression.

Authors:  Bettina M Wegenast-Braun; Ana Fulgencio Maisch; Daniel Eicke; Rebecca Radde; Martin C Herzig; Matthias Staufenbiel; Mathias Jucker; Michael E Calhoun
Journal:  Am J Pathol       Date:  2009-07       Impact factor: 4.307

10.  Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena U Amek
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.